Eureka Eurostats is the most extensive international funding programme for innovative SMEs wishing to collaborate on R&D projects. Irish SMEs can apply with the total grant capped at 60% support up to €360,000. Projects must include at least two partners independent from each other and established in at least two different Eurostars countries.
Myriad is Ireland’s leading specialist R&D grant adviser. Our talented bid writing team boasts some of Europe's highest success rates.
We’ve created five simple sections to help you understand how Eureka Eurostars works and whether your business could be eligible for funding.
Eurostars is aimed at innovative small and medium-sized enterprises with less than 250 employees who want to participate in collaborative research and innovation projects with partners across Europe and associated countries. Enterprise Ireland supports Irish SMEs who want to get involved.
SMEs can receive up to 50% of their costs of participating in a project, with a maximum grant of €450,000. The funding contribution comprises national funds (75%) and EU funds (25%).
Only SMEs performing R&D are eligible for grant funding. To qualify as a research-performing SME, you must:
Academics, universities, Research and Technology Organisations, and large companies can participate in Eurostars, but they must use funds from other sources or fund their own participation.
If you qualify as a research-performing SME, plan to develop an innovative new product, process, or service that you want to be rapidly commercialised, and work in partnership with participants in other countries, Eurostars funding may be appropriate for you.
The project duration must be 36 months or fewer, with market introduction within 24 months of completion.
You must define a project and find partners to apply for Eurostars funding. You then need to contact the National Project Coordinator in Ireland, who will guide you through the application process, guidelines, and funding opportunities.
A typical Eurostars project has 3-4 participants from 2-3 different countries, with an average project duration of 29 months and €1.4 million in average project costs.
Your Eurostars application is more likely to succeed if it:
"Marc and his team assisted Hooke Bio in securing EIC Accelerator funding (blended finance). I doubt we would have successfully navigated the complicated EIC process and portal without Marc's in-depth knowledge of the portal's structure and strategic grant writing. He has fantastic attention to detail, is easily contactable and always very clear with his feedback. Marc's assistance does not end with notification of the funding; he continues to advise, assist and put us in contact with others in his vast network who have received similar funding."
Dr Finola Cliffe
Hooke Bio Ltd
"Marc and his team have been an excellent support to Luminate, advising on DTIF and EIC Accelerator grant submissions. They have an obvious understanding of the funding requirements and have supported us through all phases, from grant writing to interview preparation. I would highly recommend him for support on deeptech funding applications."
Aaron Hannon
Luminate Medical
“Marc and the Myriad team helped us apply for and secure an EIC Accelerator Grant. I would recommend Marc and the wider team to anyone applying for this or any other type of funding. He has an incredible talent for structuring and writing technical content such that it is both easy to understand and compelling and a knowledge of the process that is second to none. Consultants often have a sometimes-earned reputation for "give me your watch, and I'll tell you the time". Marc could not be more different to this. His optimism, proactivity, resilience and sense of humour kept us going through a challenging process from beginning to end. I lost count of the number of times he has said, "Don't worry, I'll do that". He's also a great bloke, and I look forward to having the opportunity to work with him again in future.”
Dominic Griffiths
Alesi Surgical
"Marc is the best in the grant funding business, with a stellar success rate at innovation funding mechanisms. He acts as a guide to enable the reviewer to be the hero - clarifying your message so the audience will listen - and his approach works. I've heard Marc described as a great grant writer and editor, but that description is an injustice to his deep expertise, effort, and skill. We've had a 100% success rate for all applications we've worked with Marc - notably EIC Accelerator grant-first (plus future equity) success in 2021."
Stephen Cox
Invera Medical
“Kite Medical had the pleasure of working with Marc on a recent grant application to the EIC Accelerator, which was successful. Marc became part of our team during this time and was a consistent calming influence. He is so knowledgeable about this process and works so efficiently that it significantly enhanced our experience. We would be more than happy to recommend Marc and his team at Myriad.”
Joan FitzPatrick
Kite Medical
"Lauren and the Myriad team helped us apply for and secure funding through the Disruptive Technologies Innovation Fund (DTIF). Lauren was instrumental in our success, providing CergenX and the other consortium members with clear guidance, advice, and writing expertise. I look forward to continuing this working relationship, and I would recommend Lauren and the wider team to anyone applying for this or any other funding of this type."
Jason Mowles
CergenX
"The Galenband team collaborated with Lauren through Myriad to prepare our grant submission. Throughout this process, Lauren demonstrated a wealth of knowledge, offering insights and clarity on the nuanced details of a grant application. This significantly expedited and streamlined the proposal and interview preparations. We look forward to continuing our collaboration with Lauren during the grant agreement process and sincerely appreciate the support received thus far."
Oisín McGrath
Galenband
"We worked with Lauren and Marc at Myriad for over a year in preparing our submission for the EIC Accelerator, and they were a pleasure to work with during that time. They helped us with every step from proposal writing to interview preparation and were key to our success in securing the approval for a Grant-First Award of €2.5m followed by €6m in equity. We continue to work with Lauren and Marc since their experience is invaluable in the ongoing management of our grant, and it frees me up as CEO to focus on driving the business, knowing that I am in their safe, guiding hands. I couldn't recommend Lauren, Marc and Myriad highly enough!"
Peter F Doyle
BioSimulytics
"We worked with Lauren and Marc at Myriad for over a year in preparing our submission for the EIC Accelerator, and they were a pleasure to work with during that time. They helped us with every step from proposal writing to interview preparation and were key to our success in securing the approval for a Grant-First Award of €2.5m followed by €6m in equity. We continue to work with Lauren and Marc since their experience is invaluable in the ongoing management of our grant, and it frees me up as CEO to focus on driving the business, knowing that I am in their safe, guiding hands. I couldn't recommend Lauren, Marc and Myriad highly enough!"
Mark Brassil
Smart Reactors Ireland and Cerefuze Medical Devices UK Ltd
"Working with Rehman on our EIC grant submission was more than a pleasure. He has much experience in grant writing. We were successful with his expert guidance and support. I enjoyed working with Rehman; he was knowledgeable and highly motivated approach. I highly recommend working with Rehman for his professional services and personality. Thanks for all your help, Rehman! You did a great Job!"
Shahar Shaked
BioProtect Ltd
“As a result of working with Myriad, we have secured grant funding on three separate occasions, and we're currently waiting for the results of another grant application we've made. We certainly think that with Myriad’s help, we've been able to produce a very strong application.”
Chris Stanford
Arden Biotech
”Once we met with Marc, it became apparent he understands precisely what the EU is looking for. Even though it was our grant, our proposal, and it was for our company, we could feel he was invested in it. He just had little ideas that really helped to make sure we got all the marks that were going."
Dr Kate Reddington
BioProbe Diagnostics
"Marc and the Myriad team are such pros; his work ethic and attention to detail, coupled with his strategy guidance, are so compelling, and his results speak for themselves; it can't be all down to luck.”
Tony Killarney
ONK Therapeutics
Eurostars applications have a two-step evaluation process:
Myriad have an enviable track record with R&D grant applications. Using our grant application services can give you a significant competitive advantage over other grant applicants.
Our grant bid writers have secured over €300m for our clients in the last three years. We are also very proud to have secured some of the highest-scoring applications in Europe, with five of our projects scoring 15/15.
About Myriad AssociatesThe success rate for Eurostars applications is 30%.
Eurostars is open to all projects in all technology areas and market fields. Projects must have a civilian purpose.
Preparation of a Eurostars application can take up to 300 hours of work.
You will need the right combination of people to cover the application’s key aspects: the project’s implementation, market and commercialisation, and innovation. You will need to work closely with your partners.
Your Eurostars application is more likely to succeed if it:
Three independent experts first assess Eurostars applications. These experts are matched to applications by their technological expertise, familiarity with the market applications, and SME experience.
In the second evaluation stage, the Independent Evaluation Panel (IEP) scores and ranks all eligible applications. A chairperson leads the IEP, and the panel includes internationally recognised experts in the field. The IEP members cover a variety of professional sectors and are chosen according to the profiles of the applications and the technical requirements at the time.
Approximately four weeks after the submission deadline, applicants are informed whether or not their application is eligible.
Approximately 14 weeks after the submission deadline, applicants are informed whether their application is above or below the quality threshold and if it is being considered for funding.
Approximately 19 weeks after the submission deadline, applicants ranked above the quality threshold are informed of funding availability.
Within four months of the application submission deadline, the EUREKA Secretariat announces the projects that have been approved for funding.
All funding to participants is managed by their respective funding bodies, according to national funding rules and procedures.
Step 1 of #
Thanks for that!
We would like to help you decide whether your business meets the relevant criteria and whether any credits can be applied for the R&D projects you’ve undertaken. Please click on the button below to speak with an expert.
Thanks for that!
We would like to help answer any questions you have regarding the R&D tax credits scheme. Please click on the button below to speak with an expert and one of our specialist team will get in touch.
Thanks for that!
We would like to help answer any questions you have. Please click on the button below to speak with an expert and one of our specialist team will get in touch.
Speak to an expert Back